首页> 外文期刊>Bangladesh Journal of Medical Science >The Correlation between Polymorphism of β Fibrinogen Gene -455 G/A and Serum Fibrinogen Level with The Severity of Coronary Artery Stenosis In Coronary Artery Disease Patient
【24h】

The Correlation between Polymorphism of β Fibrinogen Gene -455 G/A and Serum Fibrinogen Level with The Severity of Coronary Artery Stenosis In Coronary Artery Disease Patient

机译:冠心病患者β纤维蛋白原基因-455 G / A多态性与血清纤维蛋白原水平与冠状动脉狭窄程度的相关性

获取原文
           

摘要

Background: Now a days coronary artery disease (CAD) becomes major cause of death. One among 7 deaths in America caused by CAD. CAD is an atherosclerosis process, which progresively develops into plaque that will lead to stenosis of coronary artery lumen. Several studies found that high serum fibrinogen level is an independent and significant to the severity of artery coronary stenosis. Serum fibrinogen level determined by genetic factor. Polymorphism of fibrinogen gene β -455 G/A seem plays an important role in plasma fibrinogen level. Although some studies showed a significant correlation between polymorphism and cardiovascular diseases, but some other studies report inversely. Aim. To evaluate the correlation between the polymorphism of fibrinogen gene β -455 G/A and serum fibrinogen level with the severity of artery coronary stenosis. Method: This is an analytic correlative study with prospective approach without comparison. Coronary angiography was performed in catheterization labor in the department of internal medicine, while DNA analysis and PCR done in the department of microbiology in General Hospital dr Muhammad Husin Palembang- Indonesioa, since July 2015 until Agustus 2016. Samples are CAD patient who undergo for coronary angiography and fulfield the criterias. The severity of stenosis in coronary artery determined by Gensini score. This study included 31 patient. Results . Among 31 CAD patients, this study found severe stenosis of coronary artery in 17 patients (53,1%), moderate in 5 patients (15,6%) and mild in 10 patients (31,2%). Genetic analysis showed that serum fibrinogen level was controlled by polymorphism of fibrinogen gene β -455 G/A, concecutively by genotipe AA in 15 patients (48,4%), genotipe GA in 12 patient (38,7%) and by genotipe GG in 4 patients (12,9%). Chi Square test showed a significant correlation between polymorphism gene fibrinogen β -455 G/A and serum fibrinogen level (p=0,039). Spearman’s rho test found no significant correlation between serum fibrinogen level and severity of coronary artery stenosis based on Gensini score (r=0,142; p=0,447). And also this study found no significant correlation between polymorphism gene fibrinogen β -455 G/A with the severity of stenosis in coronary artery (p=0,512). Conclusion. Although this study succeded to prove that serum fibrinogen level was determined by polymorphism fibrinogen gene β -455 G/A, but there are no significant correlations between polymorphism fibrinogen gene β -455 G/A and serum fibrinogen level with severity of coronary artery stenosis in CAD patients. This study suggest to study other candidate gene to look for other cardiac risk beside this fibrinogen.
机译:背景:如今,冠状动脉疾病(CAD)成为主要的死亡原因。 CAD在美国造成7例死亡之一。 CAD是动脉粥样硬化过程,会逐渐发展成斑块,从而导致冠状动脉腔狭窄。几项研究发现,高血清纤维蛋白原水平与动脉冠状动脉狭窄的严重程度无关并具有重要意义。血清纤维蛋白原水平由遗传因素决定。纤维蛋白原基因β-455 G / A的多态性似乎在血浆纤维蛋白原水平中起重要作用。尽管一些研究表明多态性与心血管疾病之间存在显着相关性,但另一些研究则相反。目标。探讨纤维蛋白原基因β-455 G / A多态性与血清纤维蛋白原水平与冠状动脉狭窄程度的相关性。方法:这是一项分析性相关研究,采用前瞻性方法,无可比拟。自2015年7月至2016年8月,在总医院的插管科室进行了冠状动脉造影术,而在总医院的Muhammad Husin Palembang- Indonesioa博士的微生物科进行了DNA分析和PCR。样本为接受冠状动脉造影的CAD患者血管造影和fulfield的标准。通过Gensini评分确定冠状动脉狭窄的严重程度。该研究包括31名患者。结果。在31例CAD患者中,该研究发现17例冠状动脉严重狭窄(53,1%),5例中度狭窄(15.6%)和10例中度轻度狭窄(31,2%)。遗传分析表明,血清纤维蛋白原水平受纤维蛋白原基因β-455 G / A的多态性控制,其中15例患者(48,4%)连续受到基因型AA的影响,12例患者(38.7%)连续受到基因型GA的影响,而基因型GG连续控制4例(12.9%)。卡方检验显示多态性基因纤维蛋白原β-455 G / A与血清纤维蛋白原水平之间存在显着相关性(p = 0,039)。 Spearman的rho测试显示,根据Gensini评分,血清纤维蛋白原水平与冠状动脉狭窄程度之间无显着相关性(r = 0,142; p = 0,447)。这项研究还发现,多态性基因纤维蛋白原β-455 G / A与冠状动脉狭窄程度之间无显着相关性(p = 0,512)。结论。尽管该研究成功证明血清纤维蛋白原水平是由多态性纤维蛋白原基因β-455 G / A决定的,但多态性纤维蛋白原基因β-455 G / A与血清纤维蛋白原水平与冠状动脉狭窄程度之间无显着相关性。 CAD患者。这项研究建议研究其他候选基因,以寻找这种纤维蛋白原以外的其他心脏病危险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号